María del Carmen Dominguez-Horta

Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study

M. Hernández-Cedeño, G. Guillén-Nieto, R. Santana-Sanchez, 2023, PloS one.

Aggregation properties of a therapeutic peptide for rheumatoid arthritis: A spectroscopic and molecular dynamics study

E. Placidi, M. Venanzi, F. Cavalieri, 2021, ChemPhysMater.

A peptide derived from HSP60 reduces proinflammatory cytokines and soluble mediators: a therapeutic approach to inflammation

M. Hernández-Cedeño, G. Guillén-Nieto, Anabel Serrano-Díaz, 2023, Frontiers in Immunology.

CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients

M. Béquet-Romero, E. Pentón-Arias, M. Hernández-Cedeño, 2021, Cell Stress and Chaperones.

Synergistic Anti-Inflammatory Activity of Apolipoprotein A-I and CIGB-258 in Reconstituted High-Density Lipoproteins (rHDL) against Acute Toxicity of Carboxymethyllysine in Zebrafish and Its Embryo

Dae-Jin Kang, María del Carmen Dominguez-Horta, Kyung-Hyun Cho, 2024, Pharmaceuticals.

BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba.

F. Hernández-Bernal, Y. Morera-Díaz, I. Bello-Rivero, 2023, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.